Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
In a surgical biopsy, a medical professional removes samples of cells or tissue that pathologists analyze for diseases such as cancer. By delivering these capabilities through a compact, AI-powered imaging system within the treatment room, Invenio aims to support rapid clinical decision-making.
This technology will help surgeons make intraoperative decisions when performing a biopsy or surgery, said Chris Freudiger, chief technology officer of Silicon Valley-based Invenio. They'll be able to rapidly evaluate whether the tissue sample contains cancerous cells, decide whether they need to take another tissue sample and, with the AI models Invenio is developing, potentially make a molecular diagnosis for personalized medical treatment within minutes.
Quicker diagnosis enables quicker treatment. It's especially critical for aggressive types of cancer that could grow or spread significantly in the weeks it takes for biopsy results to return from a dedicated pathology lab.
Invenio is a member of NVIDIA Inception, a program that provides cutting-edge startups with technological support and AI platform guidance. The company accelerates AI training and inference using NVIDIA GPUs and software libraries.
Laser Focus on Cancer Care The NIO Laser Imaging System accelerates the imaging of fresh tissue biopsies. Invenio's NIO Laser Imaging System is a digital pathology tool that accelerates the imaging of fresh tissue biopsies. It's been used in thousands of procedures in the U.S. and Europe. In 2021, it received the CE Mark of regulatory approval in Europe.
The company plans to adopt the NVIDIA Jetson Orin series of edge AI modules for its next-generation imaging system, which will feature near real-time AI inference accelerated by the NVIDIA TensorRT SDK.
We're building a layer of AI models on top of our imaging capabilities to provide physicians with not just the diagnostic image but also an analysis of what they're seeing, Freudiger said. With the AI performance provided by NVIDIA Jetson at the edge, they'll be able to quickly determine what kinds of cancer cells are present in a biopsy image.
Invenio uses a cluster of NVIDIA RTX A6000 GPUs to train neural networks with tens of millions of parameters on pathologist-annotated images. The models were developed using the TensorFlow deep learning framework and trained on images acquired with NIO imaging systems.
The most powerful capability for us is the expanded VRAM on the RTX A6000 GPUs, which allows us to load large batches of images and capture the variability of features, Freudiger said. It makes a big difference for AI training.
On the Path to Clinical Deployment One of Invenio's AI products, NIO Glioma Reveal, is approved for clinical use in Europe and available for research use in the U.S. to help identify areas of cancerous cells in brain tissue.
A team of Invenio's collaborators from the University of Michigan, New York University, University of California San Francisco, the Medical University of Vienna and University Hospital of Cologne recently developed a deep learning model that can find biomarkers of cancerous tumors with 93% accuracy in 90 seconds.
With this ability to analyze different molecular subtypes of cancer within a tissue sample, doctors can predict how well a patient will respond to chemotherapy - or determine whether a tumor has been successfully removed during surgery.
Beyond its work on brain tissue analysis, Invenio this year announced a clinical research collaboration with Johnson & Johnson's Lung Cancer Initiative to develop and validate an AI solution that can help evaluate lung biopsies. The AI model will help doctors rapidly determine whether collected tissue samples contain cancer.
Lung cancer is the world's deadliest form of cancer, and in the U.S. alone, lung nodules are found in over 1.5 million patients each year. Once approved for clinical use, Invenio's NIO Lung Cancer Reveal tool aims to shorten the time needed to analyze tissue biopsies for these patients.
As part of this initiative, Invenio will run a clinical study before submitting the NVIDIA Jetson-powered AI solution for FDA approval.
Subscribe to NVIDIA healthcare news.
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
02/05/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
01/05/2026
January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...
01/04/2026
January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION
Douyin Users Can Now Create And Share Videos With Stun...
02/03/2026
NBC Sports selected Imaginary Forces to create the main title sequence for the M...
02/03/2026
The NFL announces the launch of the NFL Draft Innovation Challenge, a new crowds...
02/03/2026
The World Teleport Association (WTA) has named Skyline Communications' DataMiner SatOps solution as a finalist for the 2026 Teleport Technology of the Year ...
02/03/2026
Ventum Tech announces a strategic partnership with Pixotope, a real-time graphic...
02/03/2026
Victory , a free, ad-supported sports streaming service, announces the launch of...
02/03/2026
Global powerhouse Delta Goodrem to represent Australia at this year's Eurovi...
02/03/2026
SBS brings together prominent voices to discuss rising social division and seek ...
02/03/2026
NITV Unveils Wednesday Night Sport Night
Media releases
A Midweek Hub for Blak Sport
Flagship NRL program Over The Black Dot moves to Wednesdays at 9:30pm
...
02/03/2026
Rohde & Schwarz demonstrates FR1-FR3 carrier aggregation, advancing 6G readiness Rohde & Schwarz and Qualcomm Technologies, Inc. have reached another pivotal ...
02/03/2026
MELBOURNE, Fla., March 2, 2026 - L3Harris Technologies (NYSE: LHX) today announc...
02/03/2026
Harvey Norman tops New Zealand's biggest ad spenders as retail leads and telcos and beverages sure Auckland March 3, 2026 - Nielsen's New Zealand'...
02/03/2026
aconnic AG (ISIN: DE000A0LBKW6), Munich, and Arqit Quantum Inc. (Nasdaq: ARQQ, A...
02/03/2026
Advanced Systems Group, LLC (ASG), a technology and services provider for media creatives and content owners, has appointed Jody Boatwright as Chief Strategy Of...
02/03/2026
Lightware, an industry leader in signal management, is reinforcing its commitment to simplifying complex AV environments with the continued evolution of its TPN...
02/03/2026
ZEISS Cinema opens its doors to an exclusive screening, filmmakers Q&A and hands-on showcase of the new ZEISS Aatma lens family on Tuesday, March 10, 6:00-9:00 ...
02/03/2026
To expand the creative potential of the compact Astera QuikBeam, DoPchoice introduces the SNAPBAG Round. The new light-shaping accessory transforms the powerfu...
02/03/2026
Douglas Dubler
On a rooftop in New York City, veteran photographer Douglas Dubler watched the sun's angle shift across the urban landscape, his internal cl...
02/03/2026
ZEISS is expanding its Otus ML lens family with the introduction of the new ZEISS Otus ML 1.4/35. This manual-focus lens is designed for photographers who live ...
02/03/2026
Matthews Studio Equipment now offers the new Dinkum Systems White FlexiMount and Phone Mount Kit, a compact, highly adaptable setup for mobile content creation...
02/03/2026
Luxembourg, February 26, 2026 - SES and Africa Mobile Network (AMN) have expande...
02/03/2026
02 03 2026 - Media release Ausfilm and Screen Australia launch joint UK market initiative
Ausfilm and Screen Australia have announced Partner with Australia (...
02/03/2026
Monday 2 March 2026
Saturday Night Live UK announces writing team
L-R: Jonno Johnson; Charlie Skelton; Celya AB; Omar Badawy; Gr inne Maguire; Laura Claxton; ...
02/03/2026
Back to All News
Netflix Unveils the Trailer for 53 Sundays, the New Film by Cesc Gay
Entertainment
02 March 2026
GlobalSpain
Link copied to clipboard
Dis...
28/02/2026
With two features seen in Formula 1 coverage, the broadcaster aims to bring view...
28/02/2026
Secretary of War Pete Hegseth addresses a crowd of approximately 1,500 L3Harris employees in Camden, Arkansas, as part of his Arsenal of Freedom tour....
28/02/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/02/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/02/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/02/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/02/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/02/2026
Berklee Presents Mambo Mania: Eguie Castrillo and the Berklee All-Stars Big Band...
28/02/2026
Berklee Announces Two New Summer Programs in Los Angeles The Berklee Music Business Program and Electronic Music Production and Sound Design Workshop bring imme...
28/02/2026
AI-RAN is moving from lab to field, showing that a software-defined approach is ...
28/02/2026
Autonomous networks - intelligent, self-managing telecommunications operations -...
28/02/2026
Back to All News
Final Trailer for BEASTARS Final Season Part 2' Roars Tow...
28/02/2026
New way to intentionally discover molecular glues could expand drug discovery Scripps Research scientists and colleagues show how drugs that eliminate certain d...
27/02/2026
The E.W. Scripps Company names Oliver Gray as Vice President, Network Sports and...
27/02/2026
The Gotham Sports App, the exclusive direct-to-consumer streaming home of MSG Networks and the YES Network, is now available for purchase through Prime Video fo...
27/02/2026
ESPN and the Horizon League announce a new multi-year, multi-platform media rights agreement, continuing a 38-year collaboration that began with the 1988 Midwes...
27/02/2026
At the 2026 NAB Show in Las Vegas, NETGEAR will highlight its new switch models and major updates to its Engage Controller software. The company's network d...
27/02/2026
Riedel Communications announces that Fondazione Teatro alla Scala has deployed a...
27/02/2026
Lyuno specializes in media localization, including translation, dubbing, subtitling, and voice-over services for a wide array of entertainment content. The comp...
27/02/2026
Chyron Weather 2.3, the latest edition of Chyron's weather visualization suite for broadcasters and meteorologists, recently launched.
The release includes...
27/02/2026
Telestream, which concentrates in media workflow technologies, announces expanded practical AI enhancements across its Vantage, Vantage Cloud, EDC, Stanza, and ...
Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
